GSK PLC ADR (GSK) News
Filter GSK News Items
GSK News Results
|Loading, please wait...
GSK News Highlights
- For GSK, its 30 day story count is now at 13.
- Over the past 17 days, the trend for GSK's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
- DRUG, MSCI and TEVA are the most mentioned tickers in articles about GSK.
Latest GSK News From Around the Web
Below are the latest news stories about GSK PLC that investors may wish to consider to help them evaluate GSK as an investment opportunity.
In this article, we discuss the 15 undervalued defensive stocks for 2024. To skip the detailed overview of the market and defensive stocks, go directly to the 5 Undervalued Defensive Stocks For 2024. Defensive stocks are shares of companies that remain relatively stable during economic downturns as opposed to cyclical stocks. Defensive stocks usually outperform […]
GARP stocks are less likely to plunge than growth stocks with high valuations and more likely to generate strong growth than value stocks.
The price cuts come after several companies have already announced price decreases for insulins earlier this year as they worked to avoid potential penalties under 2021's American Rescue Plan Act if they had kept prices high. Under the law, drug companies are required to rebate the Medicaid program if price increases on medicines outpace inflation - and beginning in January 2024 those rebates could even be larger than the actual net cost of the drug. According to a GSK spokesman, the company plans to cut list prices by up to 70% on Advair, up to 48% on Lamictal and 10% for Valtrex.
The group agreed there could be more economic growth and dynamism next year, Downing Street said.
Machine learning stocks are ones to watch to unlock value from your portfolio.
The U.S. Centers for Disease Control and Prevention (CDC) on Thursday issued an alert urging healthcare providers to increase immunization coverage for influenza, COVID-19 and respiratory syncytial virus (RSV). The health regulator said that low vaccination rates, coupled with ongoing increases in respiratory disease activity, could lead to more severe disease and increased healthcare capacity strain in the coming weeks. Healthcare providers should recommend antiviral medications for influenza and COVID-19 for all eligible patients, especially older adults and people with certain underlying medical condition, the CDC said.
Shares of Moderna soared around 14% on Thursday on the news that a personalized cancer vaccine, produced in partnership with Merck, reduced the risk of late-stage melanoma by 49%.
Ariel Investments, an investment management company, released its “Ariel Global Fund” third-quarter 2023 investor letter. A copy of the same can be downloaded here. In the third quarter, the Ariel Global fund traded -3.16% lower, ahead of its primary benchmark the MSCI ACWI Index’s -3.40% return while underperformed its secondary benchmark MSCI ACWI Value Index’s -1.76% […]
In this article, we will be taking a look at the 30 largest pharmaceutical companies in the world. To skip our detailed analysis, you can go directly to see the 10 Largest Pharmaceutical Companies in the World. The world’s leading pharmaceutical companies became the center of attention for people all over the world as a […]
In this article, we will list and explore the 19 countries that encourage immigration from the USA. You can skip our detailed analysis and go directly to our list of 5 Countries that Encourage Immigration from USA. Spanning across continents and cultures, residency, citizenship, and dual citizenship offer expatriates a unique bridge between their homeland […]